Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection
Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection.ANRS 112 INTERPRIM
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from French National Agency for Research on AIDS and Viral Hepatitis
- Chronic Hepatitis C · Phase PHASE3 · Jul 2012
- HBe Negative Chronic Hepatitis B · Phase PHASE3 · Dec 2008
- HIV Infections · Phase PHASE1/PHASE2 · Oct 2008
- Hepatitis B · Phase PHASE3 · Jul 2008
- Hepatitis C, Chronic · Phase PHASE3 · Dec 2006
See all terminations from French National Agency for Research on AIDS and Viral Hepatitis
This PHASE2/PHASE3 trial investigates HIV Infections and Primary Acute Infection and is currently terminated or withdrawn. French National Agency for Research on AIDS and Viral Hepatitis leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2_PHASE3
First recorded
May 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- French National Agency for Research on AIDS and Viral Hepatitis
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.